Tumor heterogeneity in EMT states also contributes to variable inter- and intralesional PD-L1 expression [88], including PD-L1 expression on cancer stem cells (via increased glycosylation resulting in improved PD-L1 protein stability), further contributing to tumor immune escape [141]. This evidence concerns the gene CD274 and cancer.